Zobrazeno 1 - 10
of 11
pro vyhledávání: '"C. W. Ritchie"'
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-9 (2022)
Abstract Introduction Regulatory bodies recommend that outcome measures used in Alzheimer’s disease (AD) clinical trials capture clinically meaningful changes for the trial participant. However, commonly used outcome measures do not reflect the ind
Externí odkaz:
https://doaj.org/article/23a62cf2afe74ecdb43a8bb11d996c4d
Autor:
S. Gregory, E. M. Bunnik, A. B. Callado, I. Carrie, C. De Boer, J. Duffus, K. Fauria, S. Forster, D. Gove, I. Knezevic, A. Laquidain, D. Pennetier, S. Saunders, S. Sparks, J. Rice, C. W. Ritchie, R. Milne
Publikováno v:
Research Involvement and Engagement, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Including participants in patient and public involvement activities is increasingly acknowledged as a key pillar of successful research activity. Such activities can influence recruitment and retention, as well as researcher exper
Externí odkaz:
https://doaj.org/article/0faf605868f140e886cb1069fb525dec
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2010 (2010)
There has been a large increase in the amount of research seeking to define or diagnose Alzheimer's disease before patients develop dementia. If successful, this would principally have clinical benefits both in terms of treatment as well as risk modi
Externí odkaz:
https://doaj.org/article/cd073f075be94a3eba6df172b872fbe2
Publikováno v:
Saunders, S, Sheehan, S, Muniz-Terrera, G, Luz, S & Ritchie, C W 2022, ' Impact of clinical symptoms and diagnosis : the electronic Person-Specific Outcome Measure (ePSOM) development programme ', Journal of patient-reported outcomes, vol. 6, no. 1, 33, pp. 33 . https://doi.org/10.1186/s41687-022-00433-2
Introduction Regulatory bodies recommend that outcome measures used in Alzheimer’s disease (AD) clinical trials capture clinically meaningful changes for the trial participant. However, commonly used outcome measures do not reflect the individual
Autor:
Gregory, S., E. M. Bunnik, A. B. Callado, I. Carrie, C. De Boer, J. Duffus, K. Fauria, S. Forster, D. Gove, I. Knezevic, A. Laquidain, D. Pennetier, S. Saunders, S. Sparks, J. Rice, C. W. Ritchie, R. Milne
Additional file 1. GRIPP2 Short form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::938bb1bbb7ac49a793acfe230fe1d01f
Autor:
C W, Ritchie
Publikováno v:
The journal of prevention of Alzheimer's disease. 1(2)
Autor:
Ikp Cheng, W. T. Wong, Wai Kei Lo, W. C. Cheung, Suk-Wai Cheng, C. W. Ritchie, Ching-Ying Chan
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 13:351-354
The present study compared oral versus Intraperitoneal (ip) ciprofioxacin (ciproxin) as primary treatment of bacterial peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD) In a randomized, prospective trial. A total of 5
Publikováno v:
International journal of geriatric psychiatry. 25(4)
Although the evidence base for the use of antipsychotics in older people with schizophrenia is generally of low quality, it tends to support the use of atypical antipsychotics. Only limited information regarding longer term adherence to these apparen
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 13
The present study compared oral versus intraperitoneal (ip) ciprofloxacin (ciproxin) as primary treatment of bacterial peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD) in a randomized, prospective trial. A total of 5
Autor:
J. C. W. Ritchie
Publikováno v:
Canadian Journal of Civil Engineering. 12:424-425